D. Colcher

发表

A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

P. Hand, J. Schlom, M. Nuti, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3.

J. Schlom, J. Magnani, D. Colcher, 1986, Cancer research.

Site specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice.

M. Tweedle, E. Martin, Keisha Milum, 2013, Bioconjugate chemistry.

Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodies.

J. Schlom, J. Carrasquillo, P. Ferroni, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Potential for Artifacts in Monitoring for the Detection of Tumor Associated Antigens (TAG-72 and CEA) in Serum from Patients Undergoing MAb-based Diagnostic and Therapeutic Protocols

J. Schlom, J. Carrasquillo, P. Ferroni, 1990, The International journal of biological markers.

Quantitative, Simultaneous PET/MRI for Intratumoral Imaging with an MRI-Compatible PET Scanner

Simon R. Cherry, Peter S. Conti, Russell E. Jacobs, 2012, The Journal of Nuclear Medicine.

Imaging glioma extent with 131I-TM-601.

A. Mamelak, J. Fiveash, S. Shen, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.

Sanjiv S Gambhir, Arion F Chatziioannou, Gobalakrishnan Sundaresan, 2005, Cancer research.

In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.

S. Fraser, J. Bading, Zibo Li, 2011, Bioconjugate chemistry.

Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy.

J. Schlom, A. Molinolo, J. Simpson, 1990, Journal of the National Cancer Institute.

In vivo tumor targeting of a recombinant single-chain antigen-binding protein.

K. D. Hardman, J. Schlom, M. Pantoliano, 1990, Journal of the National Cancer Institute.

Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo.

S. Pestka, P. Fisher, F. Guadagni, 1987, Science.

Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignancies.

M. Kalos, S. Forman, M. Jensen, 2004, Blood cells, molecules & diseases.

Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX101

R. Jacobs, T. Ng, D. Procissi, 2013, Clinical Cancer Research.

Imaging , Diagnosis , Prognosis Serial Diffusion MRI to Monitor and Model Treatment Response of the Targeted Nanotherapy CRLX 101

R. Jacobs, T. Ng, D. Procissi, 2013 .

Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies.

Yi-Jen Chen, J. Bading, J. Wong, 2020, Cancer biotherapy & radiopharmaceuticals.

A pretherapy biodistribution and dosimetry study of indium-111-radiolabeled trastuzumab in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.

J. Wong, A. Wu, J. Shively, 2010, Cancer biotherapy & radiopharmaceuticals.

Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies.

S. Mirzadeh, M. Brechbiel, J. Schlom, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Innovations that influence the pharmacology of monoclonal antibody guided tumor targeting.

S. Larson, P. Hand, J. Schlom, 1990, Cancer research.

PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine

J. Shively, S. Forman, Christine E. Brown, 2018, The Journal of Nuclear Medicine.

Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.

J. Schlom, A. Molinolo, M. Roselli, 1995, Anticancer research.

TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody

R. Rockne, J. Wong, J. Shively, 2020, The Journal of Nuclear Medicine.

Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma.

L. Leong, J. Wong, A. Wu, 2017, Cancer biotherapy & radiopharmaceuticals.

Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG‐72)

M. A. Sattler, T. Klug, J. Schlom, 1986, International journal of cancer.

Preclinical Results of Camptothecin-Polymer Conjugate (IT-101) in Multiple Human Lymphoma Xenograft Models

Mark E. Davis, Y. Yen, Jianyi Wang, 2009, Clinical Cancer Research.

A radioimmunoassay for the detection of a human tumor‐associated glycoprotein (tag‐72) using monoclonal antibody B72.3

J. Schlom, A. Paterson, H. Sears, 1986, International journal of cancer.

Diagnostic PET Imaging of Mammary Microcalcifications Using 64Cu-DOTA-Alendronate in a Rat Model of Breast Cancer

Marcia M. Miller, J. Bading, J. Shively, 2017, The Journal of Nuclear Medicine.

Cu-DOTA-Trastuzumab PET 64 Metastatic Breast Cancer Using Positive − Functional Imaging of Human Epidermal Growth Factor Receptor 2

J. Bading, P. Conti, P. Frankel, 2013 .

Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancy.

David D. Smith, S. Gillies, G. McNamara, 2007, Cancer research.

Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells

J. Shively, S. Forman, M. Cristea, 2018, Frontiers in Immunology.

Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer

J. Shively, D. Colcher, P. Yazaki, 2020, Cancer medicine.

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma

A. Nademanee, J. Bading, J. Wong, 2021, Blood advances.

Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation.

P. Hand, J. Schlom, D. Kufe, 1983, Cancer research.

High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trial.

James R. Anderson, M. Tempero, D. Colcher, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy.

A. Wu, J. Shively, J. Longmate, 2007, Cancer research.

Monodispersed DOTA-PEG–Conjugated Anti-TAG-72 Diabody Has Low Kidney Uptake and High Tumor-to-Blood Ratios Resulting in Improved 64Cu PET

J. Bading, P. Hudson, J. Shively, 2010, Journal of Nuclear Medicine.

Immunolymphoscintigraphy in breast cancer: evaluation using 131I-labeled monoclonal antibody B72.3.

R. Wahl, L. Fig, A. Chang, 1998, Nuclear medicine and biology.

Expression in COS cells of a mouse-human chimaeric B72.3 antibody.

J. Schlom, M. Bodmer, D. Colcher, 1987, Protein engineering.

Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.

M. Goris, M. Tempero, G. Adams, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cancer Therapy Using Radioimmunoconjugates

M. Tempero, S. Joshi, D. Colcher, 1993, Annals of the New York Academy of Sciences.

Mechanically interlocked functionalization of monoclonal antibodies

John C Williams, Jeremy D. King, James W. Puckett, 2018, Nature Communications.

Use of Monoclonal Antibodies to Define the Diversity of Mammary Tumor Viral Gene Products in Virions and Mammary Tumors of the Genus Mus 1

P. Hand, J. Schlom, D. Colcher, 2006 .

Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.

J. Schlom, R. Muraro, M. Roselli, 1988, Cancer research.

Serological mapping of the TAG-72 tumor-associated antigen using 19 distinct monoclonal antibodies.

M. Kuroki, J. Schlom, J. Simpson, 1990, Cancer research.

Patient-specific dosimetry of indium-111- and yttrium-90-labeled monoclonal antibody CC49.

W. Hawkins, M. Tempero, J. Baranowska-Kortylewicz, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Comparative studies on the expression of tumor‐associated glycoprotein (TAG‐72), CA 19‐9 and DU‐pan‐2 in normal, benign and malignant pancreatic tissue

M. Büchler, J. Schlom, M. Tempero, 1988, International journal of cancer.

Complementation of anti‐CEA and anti‐TAG‐72 monoclonal antibodies in reactivity to human gastric adenocarcinomas

J. Schlom, N. Ohuchi, J. Simpson, 1987, International journal of cancer.

In vivo and in vitro clinical applications of monoclonal antibodies against TAG-72.

J. Schlom, P. Ferroni, M. Roselli, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Influence of spatial configuration of carcinoma cell populations on the expression of a tumor-associated glycoprotein.

P. Hand, J. Schlom, D. Salomon, 1985, Cancer research.

Monoclonal antibodies and immobilized antibodies

C. A. White, R. Krauss, M. Melamed, 1987 .

ImmunoPET, [64Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model

J. Wong, J. Shively, I. Nair, 2019, Clinical Cancer Research.

Modulation of human tumor antigen expression.

S. Pestka, P. Hand, A. Thor, 1987, The Journal of laboratory and clinical medicine.

Monoclonal antibodies reactive with breast tumor-associated antigens.

S. Pestka, P. Fisher, P. Hand, 1985, Advances in cancer research.

A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro‐intestinal epithelium

J. Schlom, J. Simpson, R. Muraro, 1989, International journal of cancer.

Differential expression of carcinoembryonic antigen in early gastric adenocarcinomas versus benign gastric lesions defined by monoclonal antibodies reactive with restricted antigen epitopes.

J. Schlom, N. Ohuchi, R. Muraro, 1987, Cancer research.

Monoclonal antibodies to human mammary carcinoma associated antigens and their potential uses for diagnosis, prognosis, and therapy.

P. Hand, J. Schlom, D. Kufe, 1983, Laboratory and research methods in biology and medicine.

Binding to CD20 by Anti-B1 Antibody or F(ab')2 is sufficient for induction of apoptosis in B-cell lines

Yuni Fang, D. Colcher, D. King, 2002, Cancer Immunology, Immunotherapy.

Rapid and efficient production of radiolabeled antibody conjugates using vacuum diafiltration guided by mathematical modeling.

D. Bartlett, D. Colcher, A. Raubitschek, 2008, Bioconjugate chemistry.

Immunoscintigraphy in the follow-up of patients operated on for carcinoma of the sigmoid and rectum

M. Salvatore, J. Schlom, S. Lastoria, 1987, Diseases of the colon and rectum.

Generation and Characterization of a Recombinant/Chimeric B72.3 (Human γ1)

P. Hand, J. Schlom, R. Callahan, 1991 .

Combining Immunocytokine with Adoptive Immunotherapy To Treat B-Lineage Lymphomas.

G. McNamara, M. Jensen, S. Olivares, 2005 .

Non-HLA antigens in breast cancer.

J. Schlom, M. Nuti, D. Colcher, 1983, Progress in clinical and biological research.

Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study

Jinha M. Park, J. Bading, P. Frankel, 2021, The Journal of Nuclear Medicine.

Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein.

J. Bading, M. Sherman, D. Colcher, 2008, Nuclear medicine and biology.

First-In-Human Pilot PET Immunoimaging Study of 64Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers.

Yi-Jen Chen, J. Wong, A. Wu, 2022, Cancer biotherapy & radiopharmaceuticals.

Reactivity of CO17-1A and B72.3 in benign and malignant pancreatic diseases.

M. Büchler, R. Tsuchiya, J. Schlom, 1989, Human pathology.

Biology and Immunology of Human Carcinoma Cell Populations

S. Pestka, P. Fisher, R. Mariani-Costantini, 1984 .

Centralized radiolabeling of antibodies for radioimmunotherapy.

D. Colcher, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Single molecular weight discrete PEG compounds: emerging roles in molecular diagnostics, imaging and therapeutics

D. Colcher, S. Povoski, P. D. Davis, 2013, Expert review of molecular diagnostics.

Template-Catalyzed, Disulfide Conjugation of Monoclonal Antibodies Using a Natural Amino Acid Tag.

Roger E. Moore, Jeremy D. King, D. Colcher, 2018, Bioconjugate chemistry.

Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody / Streptavidin in Patients with Metastatic Colon Cancer 1

M. Goris, M. Tempero, G. Adams, 2000 .

New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinoma.

F. Guadagni, K. D. Hardman, J. Schlom, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model.

J. Wong, P. Wong, J. Shively, 2017, Cancer biotherapy & radiopharmaceuticals.

Intratumoral immunocytokine treatment results in enhanced antitumor effects

S. Gillies, R. Reisfeld, D. Colcher, 2008, Cancer Immunology, Immunotherapy.

Binding to CD 20 by Anti-B 1 Antibody or F ( ab ’ ) 2 is sufficient for induction of apoptosis in B-cell lines

Yuni Fang, D. Colcher, D. King, 2022 .

Squirrel monkey retrovirus: an endogenous virus of a new world primate

J. Schlom, D. Colcher, S. Kalter, 1977, Journal of virology.

Detection of carcinoembryonic antigen and related antigens in sera of patients with gastrointestinal tumors using monoclonal antibodies in double-determinant radioimmunoassays.

M. Herlyn, J. Schlom, H. Koprowski, 1983, Hybridoma.

Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.

J. Schlom, D. Milenic, D. Houchens, 1991, Cancer research.

A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells.

S. Riddell, Xiuli Wang, M. Sherman, 2011, Blood.

Isolation of the mouse mammary tumor virus sequences not transmitted as germinal provirus in the C3H and RIII mouse strains

R. Kettmann, J. Schlom, D. Colcher, 1977, Journal of virology.

DIVERSITY OF MOUSE MAMMARY TUMOR VIRUS GENETIC INFORMATION AND GENE PRODUCTS IN RODENTS

P. Hand, J. Schlom, R. Callahan, 1978 .

Viruses and Mammary Carcinoma

J. Schlom, D. Kufe, D. Colcher, 1978 .

Differences in mouse mammary tumor viruses: Relationship to early and late occurring mammary tumors

R. Kettmann, J. Schlom, R. Michalides, 1977, Cancer.

Distribution of Mason-Pfizer Virus-Specific Sequences in the DNA of Primates

J. Schlom, G. Schochetman, D. Colcher, 1977, Journal of virology.

Biochemical Evidence for Viral Involvement in Human Breast Cancer

S. Spiegelman, J. Schlom, R. Michalides, 1975 .

Characterization of mouse mammary tumor viruses propagated in heterologous cells.

J. Schlom, D. Colcher, Y. Teramoto, 1977, Cancer research.

Characterization of mouse mammary tumor viruses from primary tumor cell cultures. II. Biochemical and biophysical studies.

J. Schlom, R. Michalides, D. Colcher, 1976, Journal of the National Cancer Institute.

Use of monoclonal antibodies to define the diversity of mammary tumor viral gene products in virions and mammary tumors of the genus Mus.

J. Schlom, D. Colcher, D. Wunderlich, 1981, Cancer research.

Quantitation of RNA Tumor Viruses and Viruslike Particles in Human Milk by Hybridization to Polyadenylic Acid Sequences

S. Spiegelman, J. Schlom, D. Gillespie, 1973, Science.

The use of molecular hybridization to track the mode of transmission and distribution of murine mammary tumor viruses: a model for etiologic studies of human breast cancer.

R. Kettmann, J. Schlom, D. Colcher, 1978, Progress in experimental tumor research.

16 – Colon Carcinoma Cell Population as Defined by Monoclonal Antibodies

S. Pestka, P. Hand, A. Thor, 1990 .

Interspecies radioimmunoassay for the major structural proteins of primate type-D retroviruses.

J. Schlom, D. Colcher, Y. Teramoto, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Purification and characterization of the RNA-directed DNA polymerase of a primate type-D retrovirus: Mason-Pfizer virus.

J. Schlom, D. Colcher, 1980, Biochimica et biophysica acta.

Mason-Pfizer virus RNA genome: relationship to the RNA of morphologically similar isolates and other oncornaviruses

D. Colcher, W. Drohan, Schlom, 1976, Journal of virology.

Serological analysis of reverse transcriptase of the Mason-Pfizer monkey virus.

S. Spiegelman, J. Schlom, T. Ono, 1974, Virology.

Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinoma.

P. Pour, E. Uchida, R. Metzgar, 1989, The American journal of surgical pathology.

PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs.

J. Wong, P. Wong, J. Shively, 2017, Nuclear medicine and biology.

Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imaging.

J. Bading, D. Wheatcroft, P. Hudson, 2011, Bioconjugate chemistry.

Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer

Paul J Yazaki, Anna M Wu, J. Wong, 2004, Clinical Cancer Research.

Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.

J. Schlom, M. Roselli, M. Bodmer, 1989, Cancer research.

Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation

J. Wong, J. Shively, M. Sherman, 2020, Oncoimmunology.

Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.

Paul J Yazaki, Anna M Wu, J. Wong, 2006, Bioconjugate chemistry.

Low Dose Focused Ultrasound Induces Enhanced Tumor Accumulation of Natural Killer Cells

R. Jacobs, D. Colcher, S. Barnes, 2015, PloS one.

Feasibility and safety of outpatient Bexxar therapy (tositumomab and iodine I 131 tositumomab) for non-Hodgkin's lymphoma based on radiation doses to family members.

M. Kaminski, R. Wahl, J. Siegel, 2001, Clinical lymphoma.

AML ImmunoPET: 64Cu-DOTA-anti-CD33 PET-CT imaging of AML in Xenograft mouse model

J. Wong, J. Shively, I. Nair, 2019, bioRxiv.

Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma.

M. Gonda, B. Guthrie, A. Mamelak, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Functional Imaging of Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Using 64Cu-DOTA-Trastuzumab PET

J. Bading, P. Conti, P. Frankel, 2014, The Journal of Nuclear Medicine.

Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.

J. Schlom, A. Molinolo, D. Houchens, 1992, Cancer research.

High-dose therapy with 90Yttrium-labeled monoclonal antibody CC49: a phase I trial.

James R. Anderson, J. Schlom, M. Tempero, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members.

M. Tempero, J. Siegel, D. Colcher, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practice.

J. Vose, M. Tempero, J. Norenberg, 2002, Journal of the American Pharmaceutical Association.

The use of standard and relaxed hybridization conditions to detect two classes of sequences related to type-D retroviruses in the DNAs of primates.

J. Schlom, D. Colcher, W. Drohan, 1978, Biochimica et biophysica acta.

Sequence homology between the RNA of Mason-Pfizer monkey virus and the RNA of human malignant breast tumors.

S. Spiegelman, J. Schlom, D. Colcher, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Mechanically interlocked functionalization of monoclonal antibodies

Jeremy D. King, James W. Puckett, D. Colcher, 2018, Nature Communications.

Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumab.

A. Krishnan, F. Pichiorri, R. Rockne, 2020, Blood advances.

Copper 64-labeled daratumumab as a PET/CT imaging tracer for multiple myeloma.

Guido Marcucci, Jonathan Keats, Junie Chea, 2018, Blood.

Tumor Uptake of 64Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer

Jinha M. Park, J. Bading, R. Rockne, 2018, The Journal of Nuclear Medicine.

Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.

J. Wong, J. Shively, L. Williams, 2005, Bioconjugate chemistry.

Generation and characterization of monoclonal antibody B72.3. Experimental and preclinical studies.

J. Schlom, D. Milenic, D. Colcher, 1992, Targeted diagnosis and therapy.

A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance.

J. Andersen, I. Sandlie, J. Shively, 2013, Protein engineering, design & selection : PEDS.

Differential binding to human mammary and nonmammary tumors of monoclonal antibodies reactive with carcinoembryonic antigen.

P. Hand, J. Schlom, M. Nuti, 1983, Cancer Investigation.

A versatile bifunctional chelate for radiolabeling humanized anti-CEA antibody with In-111 and Cu-64 at either thiol or amino groups: PET imaging of CEA-positive tumors with whole antibodies.

Paul J Yazaki, J. Bading, J. Wong, 2008, Bioconjugate chemistry.

Immunological and structural relationships between langur virus and other primate type-D retroviruses.

J. Schlom, D. Colcher, Y. Teramoto, 1978, Virology.

A novel adhesion factor produced by hamster pancreatic cancer cell line is effective on normal and carcinoma cell lines of different species

M. Hollingsworth, P. Pour, D. Colcher, 1995, International journal of pancreatology : official journal of the International Association of Pancreatology.

Useof MolecularHybridizationto Detect Type D RetrovirusMarkers in RhesusPlacentasand Other Tissues 1

W., J. Schlom, D. Colcher, 2022 .

Humanization of the anti-CEA T84.66 antibody based on crystal structure data.

Paul J Yazaki, Anna M Wu, J. Wong, 2004, Protein engineering, design & selection : PEDS.

PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine

J. Shively, S. Forman, Christine E. Brown, 2018, The Journal of Nuclear Medicine.

Quantitative, Simultaneous PET/MRI for Intratumoral Imaging with an MRI-Compatible PET Scanner

S. Cherry, R. Jacobs, J. Bading, 2012, The Journal of Nuclear Medicine.

Pilot study of HER2 targeted 64Cu-DOTA-tagged PET imaging in gastric cancer patients

Y. Fong, Y. Woo, D. Colcher, 2023, Nuclear medicine communications.